The global Cerebrospinal Fluid Management market accounted for US$ 1.82 Bn in 2021 and is expected to grow at a CAGR of 5.3% over the forecast period 2021–2028, to account for US$ 2.61 Bn by 2028.
Cerebrospinal fluid (CSF) management involves using devices such as shunts and external drainage systems to maintain the flow of CSF and drain excess fluid from the brain. Increased intracranial pressure can result in an irreversible injury to the central nervous system. Among many functions of the cerebrospinal fluid, it protects against acute changes in venous and arterial blood pressure or impact pressure. Factors such as the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures are driving the global market. However, the lack of skilled professionals in developing economies and complications related to CSF shunt malfunctions is expected to hamper the overall market growth.
Cerebrospinal fluid management companies worldwide are scaling up production. Their involvement in various business developments and product innovations helps ensure the easy availability of the products in both domestic and international markets. Moreover, the regulatory agencies are providing the required support through timely product approvals and permissions.
The impact of COVID-19 has been far-reaching. The effects on neurological patients make them one of the worst affected groups. COVID-19 has greatly impacted the number of patients undergoing tumor diagnosis and treatment. The increased pressure due to the growing rate of hospitalization of COVID-19 patients led to the re-profiling of many hospitals and departments, including neurology clinics for treating patients with the COVID-19. The cerebrospinal fluid management market in Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. China and India are major contributors to the market growth, owing to the increasing incidences of CSF leaks and growing developments for CSF management products.
The cerebrospinal fluid management market majorly consists of players such as Medtronic plc; Integra LifeSciences Corporation; B. Braun Melsungen AG; Depuy Synthes; Sophysa SA; BeckerSmith Medical; Biometri, Spiegelberg GmbH & Co; Moller Medical GmbH, and Dispomedica GmbH. These companies have been implementing various strategies that have helped the growth of the individual companies and in turn, have brought about various favorable changes in the market. The companies have utilized organic strategies such as launches and product approvals. Moreover, inorganic strategies such as mergers & acquisitions and collaborations were widely seen in the cerebrospinal fluid management market.
Medtronic plc; Integra LifeSciences Corporation; B. Braun Melsungen AG; Depuy Synthes; Sophysa SA; BeckerSmith Medical; Biometri, Spiegelberg GmbH & Co; Moller Medical GmbH; and Dispomedica GmbH are among the leading companies operating in the cerebrospinal fluid management market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]